Curcumin prevents and reverses murine cardiac hypertrophy (Retracted article. See vol 119, pg 2113, 2009)
Curcumin prevents and reverses murine cardiac hypertrophy (Retracted article. See vol 119, pg 2113, 2009)
复制标题
DOI:
10.1172/jci32865
复制
发表时间:
2008-03-01
影响因子:
15.9
通讯作者:
Liu, Peter P.
中科院分区:
文献类型:
--
作者:
Li, Hong-Liang;Liu, Chen;Liu, Peter P.
Chromatin remodeling, particularly histone acetylation, plays a critical role in the progression of pathological cardiac hypertrophy and heart failure. We hypothesized that curcumin, a natural polyphenolic compound abundant in the spice turmeric and a known suppressor of histone acetylation, would suppress cardiac hypertrophy through the disruption of p300 histone acetyltransferase-dependent (p300-HAT-dependent) transcriptional activation. We tested this hypothesis using primary cultured rat cardiac myocytes and fibroblasts as wen as two well-established mouse models of cardiac hypertrophy. Curcumin blocked phenylephrin-induced (PE-induced) cardiac hypertrophy in vitro in a dose-dependent manner. Furthermore, curcumin both prevented and reversed mouse cardiac hypertrophy induced by aortic banding (AB) and PE infusion, as assessed by heart weight/BW and lung weight/BW ratios, echocardiographic parameters, and gene expression of hypertrophic markers. Further investigation demonstrated that curcumin abrogated histone acetylation, GATA4 acetylation, and DNA-binding activity through blocking p300-HAT activity. Curcumin also blocked AB-induced inflammation and fibrosis through disrupting p300-HAT-dependent signaling pathways. Our results indicate that curcumin has the potential to protect against cardiac hypertrophy, inflammation, and fibrosis through suppression of p300-HAT activity and downstream GATA4, NF-kappa B, and TGF-beta-Smad signaling pathways.